|
NRS1
|
Mu50; ATCC 700699 |
Staphylococcus aureus |
Vancomycin-intermediate strain isolated in 1996; whole genome sequenced at Juntendo University, Japan |
|
|
NRS70
|
N315 |
Staphylococcus aureus |
Methicillin-resistant strain isolated in 1982; whole genome sequenced at the National Institute of Technology and Evaluation, Tokyo. |
|
|
NRS71
|
Sanger 252 |
Staphylococcus aureus |
Epidemic MRSA strain sequenced at Sanger Centre, UK |
|
|
NRS72
|
Sanger 476 |
Staphylococcus aureus |
Hyper-virulent community-acquired MSSA sequenced at Sanger Centre, UK |
|
|
NRS77
|
NCTC 8325; RN1 |
Staphylococcus aureus |
Strain sequenced at Univ. of Oklahoma
|
|
|
NRS100
|
COL |
Staphylococcus aureus |
Strain sequenced at TIGR |
|
|
NRS101
|
RP62A; ATCC 35984 |
Staphylococcus epidermidis |
Slime positive strain sequenced by TIGR |
|
|
NRS123
|
MW2;C1999000459;USA400;99065 |
Staphylococcus aureus |
A community-acquired MRSA strain sequenced at the National Institute of Technology and Evaluation, Tokyo. |
|